Passage Bio
Matthew Christy possesses extensive experience in accounting, currently serving as a Senior Accountant at Passage Bio since July 2021. Prior roles include Senior Accountant positions at Venatorx Pharmaceuticals, Inc. and Aclaris Therapeutics, Inc., along with experience at Veterinary Practice Partners and InterDigital Communications. Matthew's career began with a Property Accountant role at Brixmor and included a temporary position as a Business Case Manager at Prudential Financial. Academically, Matthew holds a Bachelor of Science in Accounting from Kutztown University of Pennsylvania and an MBA from Southern New Hampshire University.
Passage Bio
1 followers
Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).